Clear.bio, based in Amsterdam, focuses on reversing type 2 diabetes through digital precision nutrition. The company has recently achieved reimbursement in the Netherlands and is now expanding internationally.

They have developed a best-in-class digital therapeutic (DTx) based on real-time glucometry, designed as a consumer product rather than a traditional medical intervention. Their approach combines a real-time sensor (IoT), an intelligent app (AI), and guidance from a dietitian to drive behavioral change.

While platforms like Spotify recommend what to listen to and Netflix suggests what to watch, clear.bio aims to guide people on what to eat.

Are you also interested to pitch your company at the next edition of Health~Holland Global Investor Forum and Innovation for Health on 10-11 March 2027 in Utrecht, the Netherlands? Then book your start-up ticket and your pitching slot via the event website.